Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative.
Acute Kidney Injury
/ diagnosis
Adult
Aged
Colorado
Continuous Renal Replacement Therapy
/ methods
Critical Illness
/ mortality
Dialysis Solutions
/ administration & dosage
Drug Administration Schedule
Female
Hospital Mortality
Hospitals, University
Humans
Intensive Care Units
Male
Middle Aged
Quality Improvement
Risk Assessment
Quality improvement
acute kidney injury (AKI)
best practices
continuous renal replacement therapy (CRRT)
critical care
dialysis dose
electronic health record (EHR)
evidence-based medicine
guideline implementation
inpatient care
intensive care unit (ICU)
nursing practice
quality of care
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
17
01
2019
accepted:
20
06
2019
pubmed:
22
9
2019
medline:
9
4
2020
entrez:
22
9
2019
Statut:
ppublish
Résumé
Clinical practice guidelines recommend delivering a continuous renal replacement therapy (CRRT) dose of 20 to 25mL/kg/h. However, practice patterns nationwide are highly variable; this inconsistent prescribing may lead to errors in medication dosing and increase rates of electrolyte and acid-base abnormalities. We describe an initiative to standardize CRRT practice patterns and reduce dosing variability. Quality improvement study. Adult patients treated with CRRT at the University of Colorado Hospital between January 2016 and October 2017. An assessment of the magnitude of the variability in CRRT dosing and the following specific interventions were implemented during the course of 1 year: (1) modification of the electronic medical record (EMR) to include calculated average 24-hour dose in real time, (2) modification of the CRRT procedure note to include comments on dosing, (3) modification of the CRRT order set to display calculations, and (4) yearly educational sessions for renal fellows outlining CRRT-specific dosing targets. The primary outcome was weekly percentage of CRRT treatments with an average delivered daily dose of 20 to 25mL/kg/h. Process and balancing outcomes included CRRT flowsheet accuracy, documentation of rates of delivered dose, and nursing satisfaction. Rates of weekly CRRT dosing in compliance with national guidelines were determined and used to create run charts showing compliance rates before and after the quality improvement interventions. Among 837 treatments before the intervention, 279 (33%) daily CRRT sessions achieved an average dose of 20 to 25mL/kg/h. Following implementation of interventions, 631 of 952 (66%) treatments achieved this goal. Week-to-week variation in dosing was significantly reduced. A single-center study generating data that may not be generalizable to institutions with different CRRT nursing models or different EMR systems. Changes to the EMR and documentation templates and education of CRRT providers about dosing were associated with doubling of the rate of appropriate CRRT dosing and reduction in dosing variability.
Identifiants
pubmed: 31540789
pii: S0272-6386(19)30890-X
doi: 10.1053/j.ajkd.2019.06.013
pmc: PMC6939344
mid: NIHMS1064980
pii:
doi:
Substances chimiques
Dialysis Solutions
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
727-735Subventions
Organisme : NIDDK NIH HHS
ID : T32 DK007135
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002537
Pays : United States
Informations de copyright
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Références
J Anaesthesiol Clin Pharmacol. 2012 Jul;28(3):386-96
pubmed: 22869954
Am J Kidney Dis. 2012 Apr;59(4):569-76
pubmed: 22244680
N Engl J Med. 2008 Jul 3;359(1):7-20
pubmed: 18492867
EDTNA ERCA J. 2002;Suppl 2:43-5, 53
pubmed: 12371723
Intensive Care Med. 2005 Dec;31(12):1693-9
pubmed: 16244877
Clin Infect Dis. 2001 Mar 1;32(5):686-93
pubmed: 11229835
N Engl J Med. 2009 Oct 22;361(17):1627-38
pubmed: 19846848
J Crit Care. 2002 Dec;17(4):246-50
pubmed: 12501152
Am J Kidney Dis. 2014 Sep;64(3):394-401
pubmed: 24815216
Kidney Int. 1998 Dec;54(6):1817-31
pubmed: 9853246
Am J Kidney Dis. 2007 Nov;50(5):712-20
pubmed: 17954284
Crit Care Med. 2006 Jul;34(7):1913-7
pubmed: 16715038
Pharmacotherapy. 2008 May;28(5):600-13
pubmed: 18447659
JAMA. 1996 May 15;275(19):1489-94
pubmed: 8622223
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715
Crit Care Med. 2002 Sep;30(9):2051-8
pubmed: 12352040
Clin J Am Soc Nephrol. 2011 Mar;6(3):467-75
pubmed: 21115626
J Am Soc Nephrol. 2006 Apr;17(4):1135-42
pubmed: 16495381
Intensive Care Med. 2007 Sep;33(9):1563-70
pubmed: 17594074
Am J Kidney Dis. 2013 May;61(5):649-72
pubmed: 23499048